Glutamine regulates the human epithelial intestinal HCT-8 cell proteome under apoptotic conditions. 2007

Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
Groupe Aden EA3234, Université de Rouen, IFRMP23, 22 boulevard Gambetta, 76183 Rouen cedex 1, France.

Glutamine plays a key role in the metabolism of rapidly dividing cells, including enterocytes and lymphocytes, which may contribute to its beneficial clinical effects. Gut mucosal homeostasis is achieved through a balance between cell proliferation and apoptosis. In T cells, glutamine up-regulates antiapoptotic proteins and down-regulates proapoptotic proteins. In gut mucosa, glutamine prevents apoptosis in rat epithelial cell lines, whereas glutamine starvation induces apoptosis through caspase activation. Finally glutamine specifically prevents tumor necrosis factor-alpha-related apoptosis in the human intestinal cell line HT-29. Comparative functional proteomics enables the characterization of each differentially expressed protein in intestinal cells in response to modifications of nutritional environment. The influence of glutamine on intestinal proteome expression in apoptotic conditions has not been studied and evaluated. This comparative proteomics study was performed in the human epithelial intestinal cell line HCT-8 under experimental apoptotic conditions to investigate the influence of glutamine on protein expression during apoptosis. The pharmaconutritional effects of glutamine were determined under 2 mm (physiological concentration) and 10 mm (pharmaconutritional concentration) conditions. About 1,800 protein spots were revealed in both conditions. Comparative assessments indicated that 28 proteins were differentially expressed significantly (i.e. at least 2-fold modulated and Student's t test with p </= 0.05) in response to an increase of glutamine concentration in the culture medium. Twenty-four proteins were identified by mass spectrometry and associated databases. From these proteins, 34% are involved in cell cycle and apoptosis mechanisms, 17% are involved in signal transduction, and 13% are involved in cytoskeleton organization. These data were integrated in a proposed schema of the interactome under apoptotic conditions. In conclusion, this study provides the first holistic picture of proteome modulation by glutamine in a human enterocytic cell line under apoptotic conditions and supports further evaluation of nutritional modulation of human intestinal proteome in various pathological conditions where apoptosis may be involved.

UI MeSH Term Description Entries
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002457 Cell Extracts Preparations of cell constituents or subcellular materials, isolates, or substances. Cell Extract,Extract, Cell,Extracts, Cell
D005973 Glutamine A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells. D-Glutamine,L-Glutamine,D Glutamine,L Glutamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings
D015180 Electrophoresis, Gel, Two-Dimensional Electrophoresis in which a second perpendicular electrophoretic transport is performed on the separate components resulting from the first electrophoresis. This technique is usually performed on polyacrylamide gels. Gel Electrophoresis, Two-Dimensional,Polyacrylamide Gel Electrophoresis, Two-Dimensional,2-D Gel Electrophoresis,2-D Polyacrylamide Gel Electrophoresis,2D Gel Electrophoresis,2D PAGE,2D Polyacrylamide Gel Electrophoresis,Electrophoresis, Gel, 2-D,Electrophoresis, Gel, 2D,Electrophoresis, Gel, Two Dimensional,Polyacrylamide Gel Electrophoresis, 2-D,Polyacrylamide Gel Electrophoresis, 2D,Two Dimensional Gel Electrophoresis,2 D Gel Electrophoresis,2 D Polyacrylamide Gel Electrophoresis,Electrophoresis, 2-D Gel,Electrophoresis, 2D Gel,Electrophoresis, Two-Dimensional Gel,Gel Electrophoresis, 2-D,Gel Electrophoresis, 2D,Gel Electrophoresis, Two Dimensional,PAGE, 2D,Polyacrylamide Gel Electrophoresis, 2 D,Polyacrylamide Gel Electrophoresis, Two Dimensional,Two-Dimensional Gel Electrophoresis
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020543 Proteome The protein complement of an organism coded for by its genome. Proteomes

Related Publications

Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
July 2006, Biochimie,
Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
December 2005, Biochimie,
Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
March 2009, Gastroenterology,
Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
September 1991, British journal of cancer,
Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
January 2016, Applied microbiology and biotechnology,
Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
October 2017, Toxins,
Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
June 2006, The Journal of nutrition,
Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
August 2004, Clinical nutrition (Edinburgh, Scotland),
Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
March 2003, Pediatric research,
Nicolas Deniel, and Rachel Marion-Letellier, and Roland Charlionet, and François Tron, and Jérôme Leprince, and Hubert Vaudry, and Philippe Ducrotté, and Pierre Déchelotte, and Sandrine Thébault
January 2013, Molekuliarnaia biologiia,
Copied contents to your clipboard!